GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma Trading AD (XBUL:SFT) » Definitions » Change In Receivables

Sopharma Trading AD (XBUL:SFT) Change In Receivables : лв0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Sopharma Trading AD Change In Receivables?

Sopharma Trading AD's change in receivables for the quarter that ended in Jun. 2024 was лв0 Mil. It means Sopharma Trading AD's Accounts Receivable stayed the same from Mar. 2024 to Jun. 2024 .

Sopharma Trading AD's change in receivables for the fiscal year that ended in Dec. 2023 was лв0 Mil. It means Sopharma Trading AD's Accounts Receivable stayed the same from Dec. 2022 to Dec. 2023 .

Sopharma Trading AD's Accounts Receivable for the quarter that ended in Jun. 2024 was лв277 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Sopharma Trading AD's Days Sales Outstanding for the three months ended in Jun. 2024 was 56.53.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sopharma Trading AD's liquidation value for the three months ended in Jun. 2024 was лв-225 Mil.


Sopharma Trading AD Change In Receivables Historical Data

The historical data trend for Sopharma Trading AD's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma Trading AD Change In Receivables Chart

Sopharma Trading AD Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sopharma Trading AD Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sopharma Trading AD Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was лв0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sopharma Trading AD  (XBUL:SFT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sopharma Trading AD's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=276.882/446.903*91
=56.53

2. In Ben Graham's calculation of liquidation value, Sopharma Trading AD's accounts receivable are only considered to be worth 75% of book value:

Sopharma Trading AD's liquidation value for the quarter that ended in Jun. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=11.205-569.308+0.75 * 276.882+0.5 * 251.231
=-225

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sopharma Trading AD Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sopharma Trading AD's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Sopharma Trading AD Business Description

Traded in Other Exchanges
N/A
Address
Sunrise Street, Lachezar Stanchev, 5 Sopharma, Business Towers, Building A Floor 12, Sofia, BGR, 1756
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.

Sopharma Trading AD Headlines

No Headlines